The Cooper Companies, Inc. $COO Shares Bought by IFP Advisors Inc

IFP Advisors Inc grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 943.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 9,443 shares of the medical device company’s stock after purchasing an additional 8,538 shares during the period. IFP Advisors Inc’s holdings in Cooper Companies were worth $774,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Capital World Investors lifted its position in shares of Cooper Companies by 25.7% during the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after acquiring an additional 2,159,233 shares during the period. State Street Corp increased its stake in shares of Cooper Companies by 1.2% during the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock worth $616,227,000 after purchasing an additional 104,910 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Cooper Companies by 332.9% during the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Sustainable Growth Advisers LP raised its position in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its position in shares of Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after purchasing an additional 1,683,561 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently issued reports on COO. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Barclays lifted their price objective on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Needham & Company LLC lifted their price objective on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research report on Friday, March 6th. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. Finally, Citigroup cut their price objective on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Price Performance

COO stock opened at $62.55 on Monday. The stock has a market capitalization of $12.20 billion, a P/E ratio of 30.97, a PEG ratio of 1.61 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a 50 day moving average price of $66.92 and a two-hundred day moving average price of $75.18.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.